학술논문
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment.
Document Type
Article
Author
Source
Hospital Pediatrics; Jan2021, Vol. 11 Issue 1, p88-93, 6p
Subject
Language
ISSN
21541663